These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 27929743
1. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey. Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M. MAbs; 2017; 9(2):383-390. PubMed ID: 27929743 [Abstract] [Full Text] [Related]
2. Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey. Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M, CRI (Club “Rhumatismes et Inflammations”). BioDrugs; 2016 Dec; 30(6):585-592. PubMed ID: 27848166 [Abstract] [Full Text] [Related]
5. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan. Oqal M, Hijazi B, Alqudah A, Al-Smadi A, A Almomani B, Alnajjar R, Abu Ghunaim M, Irshaid M, Husam A. Int J Clin Pract; 2022 Dec; 2022():8080308. PubMed ID: 35832802 [Abstract] [Full Text] [Related]
6. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France. Adé A, Bourdon O, Bussières JF. Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527 [Abstract] [Full Text] [Related]
8. Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey. Frantzen L, Cohen JD, Tropé S, Beck M, Munos A, Sittler MA, Diebolt R, Metzler I, Sordet C. Joint Bone Spine; 2019 Jul; 86(4):491-496. PubMed ID: 30659920 [Abstract] [Full Text] [Related]
10. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians. Barbier L, Vandenplas Y, Simoens S, Declerck P, Vulto AG, Huys I. J Pharm Policy Pract; 2021 Jun 22; 14(1):53. PubMed ID: 34158128 [Abstract] [Full Text] [Related]
12. [Knowledge and perceptions of biosimilar medicines by health professionals in Tunisia]. Mhiri A, Khemakhem M, Kalboussi N, Kacem B. Ann Pharm Fr; 2022 May 22; 80(3):327-339. PubMed ID: 34428456 [Abstract] [Full Text] [Related]
13. Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study. Aladul MI, Fitzpatrick RW, Chapman SR. BMJ Open; 2018 Nov 18; 8(11):e023603. PubMed ID: 30455389 [Abstract] [Full Text] [Related]
14. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners. Foreman E, Patel H, Siderov J, Harchowal J, Bubalo J, Chan A. J Oncol Pharm Pract; 2020 Apr 18; 26(3_suppl):22-32. PubMed ID: 32268828 [Abstract] [Full Text] [Related]
15. Knowledge, attitudes, and practices of pharmacists toward biosimilar medicines in Nigeria. Okoro RN, Hedima EW, Aguiyi-Ikeanyi CN. J Am Pharm Assoc (2003); 2022 Apr 18; 62(1):79-85.e2. PubMed ID: 34654651 [Abstract] [Full Text] [Related]
17. Pharmacists' Perspectives of Biosimilars: A Systematic Review. Mohd Sani N, Aziz Z, Panickar R, Kamarulzaman A. BioDrugs; 2022 Jul 18; 36(4):489-508. PubMed ID: 35776294 [Abstract] [Full Text] [Related]
18. Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey. Aladul MI, Fitzpatrick RW, Chapman SR. BioDrugs; 2017 Oct 18; 31(5):439-446. PubMed ID: 28752242 [Abstract] [Full Text] [Related]